Company Info

Number of Employees

1200

Visit Website

CiToxLAB

CRO

Tagline

Safety and Health Research Laboratories

Overview

With seven facilities located in France (Evreux and Saint-Nazaire), Canada (Laval and Boisbriand), Denmark (Copenhagen), Hungary (Veszprem) and the US (Kansas City), Citoxlab Group offers a comprehensive range of non-clinical services to meet the needs of pharmaceutical, biotechnology, medical device, chemical and agrochemical companies worldwide. Citoxlab carries out studies in general and reproductive toxicology, carcinogenicity, immunology, pharmacology, pharmacokinetics and bioanalysis/biomarkers. Citoxlab and Atlanbio (Saint Nazaire) offer both preclinical and clinical bioanalysis and biomarkers services. With Accellab (Boisbriand) in the group, Citoxlab offers efficacy and safety studies for medical devices (cardiology, ENT, orthopaedics, and regenerative medicine). A partnership with Stemina (Madison, USA) allows the Group to offer screening services using human embryonic stem cell models. Today, Citoxlab has more than 1,200 employees working at seven sites representing 760,000 sq ft (71,000 m²) of state-of-the-art facilities. The company has a world-class, top-level management team in scientific, financial and business activities.
www.citoxlab.com or contact@citoxlab.com

Company Services

Services/CapabilitiesCRO

+ Clinical Services

PK & PD (Pharmacokinetic/Pharmacodynamics)

+ Preclinical Services

Analytical Testing
Bioanalytical Testing
Bioequivalence & Bioavailability
DMPK (ADME)
General Toxicology
In Vivo Pharmacology
Method Development & Validation

Company Info

CiToxLAB

Tagline

Overview

Company Services

Services/CapabilitiesCRO

Contributions

Citoxlab Acquires Solvo Biotechnology

CitoxLab acquires Xenometrics, an American CRO specialized in preclinical assessment of new drug candidates